ORAL ADMINISTRATION OF ALPHA INTERFERON TO TREAT LUNG MALIGNANCIES

摘要

A pharmaceutical composition for treating or preventing lung malignancy in mammal comprising recombinant DNA human alpha interferon (rhIFN-α), a use of rhIFN-α for the manufacture of a medicament for treating or preventing a lung malignancy in mammals as well as a method of treating or preventing a lung malignancy in a mammal by administering by oral inhalation to such a mammal afflicted with a lung malignancy an effective amount of rhIFN-α via a nebulizer or metered dose inhaler are disclosed.